• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Further Research Needed for HPV-Related Cancer Surveillance

by Bryn Nelson, PhD • September 1, 2013

  • Tweet
  • Email
Print-Friendly Version
Further Research Needed for HPV-Related Cancer Surveillance

The sharp rise in HPV-related cancers—now a leading cause of head and neck tumors—has added another big wrinkle to post-treatment surveillance. Such cancers respond well to treatment and are not associated with either smoking or drinking. That means patients don’t carry the traditional risk factors for a second primary tumor and may not need to be screened at all after the first post-treatment scan, said Dr. Gourin.

You Might Also Like

  • HPV-Oropharyngeal Cancer Link May Affect Cancer Screening and Prognosis: The link offers potential for improved detection and prevention, but more research is needed
  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • HPV Related to Rise in Head and Neck Cancers
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer
Explore This Issue
September 2013

Mike Yao, MD, clinical associate professor of otolaryngology at New York Medical College in Valhalla, sees HPV-related head and neck cancer as fertile ground for further research on the utility of PET/CT surveillance. “There probably needs to be specific studies on specific patient groups, and that’s one group that I would guess is not going to pan out,” he said. As part of its research repertoire, in fact, the University of Pittsburgh Medical Center is conducting a study addressing the possibility of de-escalating PET/CT in patients with HPV-related cancer. Dr. Branstetter said individualizing testing protocols based on physical and radiologic examinations, HPV status and other factors will help doctors “get the best bang for the buck, because these are expensive tests and we don’t want to be overutilizing, the way we are now.”

A separate study at the university is investigating whether there’s any scientific validity to waiting three months for the first post-treatment imaging test; “We argue that two months may be the optimum time,” Dr. Branstetter said. Clinicians there are also comparing the efficacy of PET/CT to CT alone in a randomized controlled trial.

Inconsistent methods and variable physician skill levels, however, can contribute to high false positive rates and complicate meta-analyses or direct comparisons among different medical institutions. “The bottom line is that I think there is a significant amount of geographic variation,” said Dr. Funk. “And I think it is very much dependent upon the quality of the PET/CT scans, the quality of the interpretation and the ability of the ordering physicians to speak directly to a knowledgeable nuclear medicine physician about the interpretation.”

Filed Under: Features, Head and Neck, Practice Focus Tagged With: cancer, CT Scan, HPV, PET scan, surveillanceIssue: September 2013

You Might Also Like:

  • HPV-Oropharyngeal Cancer Link May Affect Cancer Screening and Prognosis: The link offers potential for improved detection and prevention, but more research is needed
  • New Staging System Proposed for HPV-Related Oropharyngeal Cancer
  • HPV Related to Rise in Head and Neck Cancers
  • Tests Emerging as Standards for Diagnosing HPV-Positive Oropharyngeal Cancer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Best Site for Pediatric TT Placement: OR or Office?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Keeping Watch for Skin Cancers on the Head and Neck

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939